You may have heard about NumPy and wondered why it seems so essential to data analysis in Python. What makes NumPy seemingly end up everywhere in statistical calculations with Python? Here are some ...

Cove Street Capital analyzes the AI market mania and shifting software valuations. Read the full analysis for more details.

Red Hat's Ansible automation platform evolves for agentic AI with ephemeral MCP servers, expanded Lightspeed AI capabilities, and workflow tools.

Random numbers are very important to us in this computer age, being used for all sorts of security and cryptographic tasks. [Theory to Thing] recently built a device to generate random numbers ...

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...

IBM’s Software and Chief Commercial Officer, Rob Thomas, wrote in a Monday blog post that translating COBOL code isn’t equivalent to modernizing enterprise syst ...

Capcom has announced that Resident Evil Requiem has already sold over 5 million copies since its release on 27th February 2026 (thanks, Eurogamer). Yeah, that's 5 million in less than a week, folks.

AI safety tests found to rely on 'obvious' trigger words; with easy rephrasing, models labeled 'reasonably safe' suddenly fail, with attacks succeeding up to 98% of the time. New corporate research ...

This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...

Human MAP1LC3B (LC3B) binds proteins involved in autophagy and other cellular processes using a degenerate four-residue short linear motif known as the LC3-interacting region (LIR). Biochemical and ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...